Ignite Creation Date:
2024-05-06 @ 10:53 AM
Last Modification Date:
2024-10-26 @ 12:37 PM
Study NCT ID:
NCT03375502
Status:
COMPLETED
Last Update Posted:
2021-05-14
First Post:
2017-11-28
Brief Title:
A Study of MG1111 in Healthy Children
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
A Phase IIIII Single-blindStage 1 Double-blindedStage 2 Randomized Active-controlled Dose-escalationStage 1 Non-inferiorityStage 2 Study to Evaluate Immunogenicity and Safety of MG1111 in Healthy Children
Status:
COMPLETED
Status Verified Date:
2017-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To assess the safety of MG1111 and to evaluate immunological non-inferiority of MG1111 versus comparator
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None